Public notice: Guideline Development Group Meeting on Targeted Next-Generation Sequencing for Detection of TB Drug Resistance

Overview

The World Health Organization (WHO) Global TB Programme (GTB)  would like to announce an upcoming Guideline Development Group meeting on the use of targeted Next-Generation Sequencing (tNGS) for detection of TB drug resistance, to be held 2-5 May 2023 in the WHO headquarters in Geneva, Switzerland.  The objectives of the  meeting are to assess the available evidence on the accuracy, the impact on patient-important outcomes, the costs and cost-effectiveness, and the feasibility, acceptability, and potential impact on equity of tNGS solutions for diagnosis of DR-TB; and to issue global recommendations and guidance on the clinical and programmatic use of tNGS solutions for detection of TB drug resistance.

 

WHO Team
Global Programme on Tuberculosis and Lung Health (GTB)